3 November 2022
A new study, involving researchers in the departments of Chemistry and Biochemistry and the Kavli Institute, sheds light on how Gram-negative bacteria like E. coli construct their outer membrane to resemble body armour, which has far-reaching implications for the development of antibiotics.
$3m Rockefeller Foundation funding to strengthen pandemic surveillance and response innovation co-developed by Oxford biologists
1 November 2022
The Rockefeller Foundation has announced $3 million in new funding for Global.health (G.h) – a first-of-its-kind, open-source platform for scientific pandemic data.
7 October 2022
Researchers from the University of Oxford have today reported findings from a large-scale study that examined the impact of the UK’s MenACWY vaccination programme on the carriage of meningitis bacteria in the throats of UK teenagers.
29 September 2022
Researchers from Oxford University’s Department of Materials have developed a technique to precisely manipulate and place nanowires with sub-micron accuracy. This discovery could accelerate the development of even smaller and more powerful computer chips.
26 September 2022
A new study involving Oxford's Department of Engineering Science has found that monitoring night-time blood pressure is important in preventing cardiovascular disease such as stroke or heart failure.
18 August 2022
A team led by researchers from Oxford Chemistry have recently published a study in Nature Communications investigating the mechanism behind a resistance to the drug ivosidenib that has developed in some types of cancer.
8 August 2022
Researchers at the Ineos Oxford Institute for Antimicrobial Resistance (IOI) and the Department of Biology have revealed links between the presence of bacteria that is resistant to antibiotics in mothers and their newborn babies, drawing on data from seven low- and middle-income countries in Africa and South Asia.
15 July 2022
Oxford biologists are part of an international team that has been modelling the cancer-suppressing p53 gene to identify how 20 different molecules unique to elephants are activated for increased sensitivity and response against carcinogenic conditions – with implications for cancer treatments in humans.
1 June 2022
The 'Explore Science Together' event takes place at the Oxford University Museum of Natural History on Tuesday 7 June.
1 June 2022
Funding to train the next generation of cutting-edge antimicrobial resistance researchers has been announced by Ineos Oxford Institute (IOI), the University of Oxford, and the University of Cambridge.
5 May 2022
Dorothy Crowfoot Hodgkin made key contributions to Medical Sciences and was the third woman to win the Nobel Prize in Chemistry.
8 February 2022
Researchers at Oxford University have implanted a novel closed-loop research platform for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in Parkinson’s-like Multiple Systems Atrophy (MSA).
26 January 2022
A £11 million Cancer Research UK investment has been awarded to the University of Oxford and Oxford-based NHS to catalyse the translation of its world-leading cancer research for patient benefit.
6 January 2022
Scientists have found evidence that a type of the antibiotic resistant superbug MRSA arose in nature long before the use of antibiotics in humans and livestock, which has traditionally been blamed for its emergence.
6 January 2022
A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms.
16 November 2021
A carbon capture company established less than a year ago by two Oxford students has been announced as one of 23 winners of the XPRIZE student competition.
9 November 2021
The HumBug project has developed methods to detect and identify different species of mosquitoes using the acoustic signature (sound) of their flight tones, captured on an inexpensive smartphone.
5 November 2021
Oxford University today joins a consortium led by the digital quantum computing company, SEEQC, to build and deliver a full-stack quantum computer for pharmaceutical drug development for Merck KGaA.
New research provides compelling evidence of the connection between AMR surgical-site infections and arthropods
30 September 2021
AMR could render many of the current mainstay and last-resort antibiotics useless, resulting in many more deaths from previously treatable infections. In 2019, a UN report estimated that drug-resistant microbes could lead to ten million deaths per year, and cost the world $100trn, by 2050.